Dual-Target Compounds Could Lead to Single and More Effective Therapy for Parkinson’s, Study Reports

Pharmacologic compounds that can act on two target molecules show promise as potential therapies for Parkinson’s disease, according to a study that details a new way of finding such compounds. The study, “Docking screens for dual inhibitors of disparate drug targets for Parkinson’s disease,” was published in…